Newer anti-psychotics may be over-prescribed

By ACSH Staff — Jan 10, 2011
Newer antipsychotic drugs currently approved to treat schizophrenia are being increasingly prescribed for off-label indications, according to a study published in Pharmacoepidemiology and Drug Safety.

Newer antipsychotic drugs currently approved to treat schizophrenia are being increasingly prescribed for off-label indications, according to a study published in Pharmacoepidemiology and Drug Safety.

Circumcision provides partial HPV protection

By ACSH Staff — Jan 10, 2011
We have known for many years that cervical cancer is a sexually transmitted disease (STD), but it wasn’t until recently that we discovered that the human papillomavirus (HPV) was the main infectious cause. While vaccines against HPV have been developed, many women in developing nations don’t have realistic access to them, and cervical cancer remains the second most common cancer killer in women worldwide.

We have known for many years that cervical cancer is a sexually transmitted disease (STD), but it wasn’t until recently that we discovered that the human papillomavirus (HPV) was the main infectious cause. While vaccines against HPV have been developed, many women in developing nations don’t have realistic access to them, and cervical cancer remains the second most common cancer killer in women worldwide.

Too much of a good thing? Fluoride water levels to be lowered

By ACSH Staff — Jan 10, 2011
Only a century ago, Americans could expect to lose most of their teeth by age 40. But, since fluoridation of tap water was introduced in the mid-twentieth century, the incidence of tooth decay has nosedived. Now, however, the Department of Health and Human Services (HHS) and the EPA have announced that they want to reduce the maximum allowable fluoride levels in municipal water supplies as recent data showed that more than one in three U.S.

Only a century ago, Americans could expect to lose most of their teeth by age 40. But, since fluoridation of tap water was introduced in the mid-twentieth century, the incidence of tooth decay has nosedived. Now, however, the Department of Health and Human Services (HHS) and the EPA have announced that they want to reduce the maximum allowable fluoride levels in municipal water supplies as recent data showed that more than one in three U.S.

Gothamist Calls On ACSH To Combat "Anti-Dentites" Against Fluoridation

By ACSH Staff — Jan 09, 2011
In New York City, Queens borough Councilman Peter Vallone Jr. is introducing a bill to eliminate fluoride from the city's tap water, claiming it "amounts to forced medication by the government."

In New York City, Queens borough Councilman Peter Vallone Jr. is introducing a bill to eliminate fluoride from the city's tap water, claiming it "amounts to forced medication by the government."

Calming Irritable Bowel Syndrome with an antibiotic

By ACSH Staff — Jan 07, 2011
Affecting up to one in five Americans, irritable bowel syndrome (IBS) is a common gastrointestinal ailment that may cause abdominal pain, bloating, diarrhea and constipation, particularly in women. Therefore, it’s important to get patients with IBS effective treatments. Yet, because the cause (or causes) of the disorder have never been fully understood, that has been difficult to accomplish.

Affecting up to one in five Americans, irritable bowel syndrome (IBS) is a common gastrointestinal ailment that may cause abdominal pain, bloating, diarrhea and constipation, particularly in women. Therefore, it’s important to get patients with IBS effective treatments. Yet, because the cause (or causes) of the disorder have never been fully understood, that has been difficult to accomplish.

New indication for RA drug helps tackle disease

By ACSH Staff — Jan 07, 2011
Based on phase III data from a recent study, the FDA has expanded the indication for Actemra, the rheumatoid arthritis (RA) drug tocilizumab. The Actemra label now includes inhibition and slowing of structural joint damage and improvement of physical function in adult patients with moderately to severely active RA, when given in combination with methotrexate. RA is a debilitating disease afflicting almost two million Americans.

Based on phase III data from a recent study, the FDA has expanded the indication for Actemra, the rheumatoid arthritis (RA) drug tocilizumab. The Actemra label now includes inhibition and slowing of structural joint damage and improvement of physical function in adult patients with moderately to severely active RA, when given in combination with methotrexate.
RA is a debilitating disease afflicting almost two million Americans.

Chinese tobacco a veritable fifth column against anti-smoking efforts

By ACSH Staff — Jan 07, 2011
Many people may find it surprising to learn that China s 300 million smokers consume a third of the world s cigarettes. But then 60 percent of Chinese men smoke an average of 15 cigarettes per day. The result, according to the International Union Against Tuberculosis and Lung disease, is that smoking-related diseases cause one million Chinese deaths each year, and this number is projected to double by the 2020.

Many people may find it surprising to learn that China s 300 million smokers consume a third of the world s cigarettes. But then 60 percent of Chinese men smoke an average of 15 cigarettes per day. The result, according to the International Union Against Tuberculosis and Lung disease, is that smoking-related diseases cause one million Chinese deaths each year, and this number is projected to double by the 2020.

Experimental drug for triple-negative breast cancer may be a triple threat

By ACSH Staff — Jan 07, 2011
Triple-negative breast cancer is typically difficult to treat because these cancer cells lack estrogen and progesterone receptors as well as large quantities of HER-2/neu protein, all of which are targets of existing drugs. This type of cancer affects approximately 15 percent of all breast cancer patients.

Triple-negative breast cancer is typically difficult to treat because these cancer cells lack estrogen and progesterone receptors as well as large quantities of HER-2/neu protein, all of which are targets of existing drugs. This type of cancer affects approximately 15 percent of all breast cancer patients.

FDA sets guidelines on its regulation of tobacco products

By ACSH Staff — Jan 06, 2011
Following up on a 2009 law which gave it the power to regulate tobacco products, the FDA announced yesterday that manufacturers must report to the agency by March 22 on whether their products are in any way more dangerous or more addictive than items which were on the market by February 15, 2007. ACSH's Dr.

Following up on a 2009 law which gave it the power to regulate tobacco products, the FDA announced yesterday that manufacturers must report to the agency by March 22 on whether their products are in any way more dangerous or more addictive than items which were on the market by February 15, 2007. ACSH's Dr.

Fish oil and coronary disease: A possible treatment

By ACSH Staff — Jan 06, 2011
A report in the Journal of the American College of Cardiology provides further evidence that some patients with weakened hearts may benefit from eating a diet high in omega-3 polyunsaturated fatty acids (PUFAs). These fatty acids are typically found in fish oil.

A report in the Journal of the American College of Cardiology provides further evidence that some patients with weakened hearts may benefit from eating a diet high in omega-3 polyunsaturated fatty acids (PUFAs). These fatty acids are typically found in fish oil.